NEWS

NightWare Launches Campaign to Disrupt Nightmares
December 4, 2024
FDA-Cleared Digital Therapeutic Treats PTSD Nightmares
Visit
(opens in a new tab)

NightWare Leadership Transition
July 25, 2024

NightWare Announces Leadership Transition and Strategic Investment Plan

Visit
(opens in a new tab)

The Jed Burgh Podcast

December 23, 2021

General Peter Chiarelli discusses Nightmare Disorder and its effect on current and former members of the military.

Listen
(opens in a new tab)

Forward Podcast

October 15, 2021

General Peter Chiarelli talks about nightmares, PTS, traumatic injuries and NightWare on the Derek Herrera podcast "Forward"

Listen
(opens in a new tab)

Star Tribune

August 13, 2021

NightWare raises $1M to further develop technology to help PTSD sufferers

Read More
(opens in a new tab)

NPR

December 6, 2020

He Designed A Smartwatch App To Help Stop His Dad's Nightmares

Read More
(opens in a new tab)

Wired Magazine
December 1, 2020

How a Vibrating Smartwatch Could Be Used to Stop Nightmares

Read More
(opens in a new tab)

Psychiatric Times

November 16, 2020

A new prescription smartwatch app may improve sleep quality for those with nightmare disorders

Read More
(opens in a new tab)

Drug and Device Digest
November 6, 2020
Market Authorizations: NIGHTWARE App for PTSD sleep disturbance, INMAZEB for Ebola treatment, REACTIV8 Implantable Neurostimulation System for pain, MAKENA withdrawal proposal
Read More
(opens in a new tab)

BioWorld
November 9, 2020
FDA gives green light for therapeutic to reduce sleep disturbance related to nightmares
Read More
(opens in a new tab)

Food and Drug Administration

November 6, 2020

FDA Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults

Read More
(opens in a new tab)

Minnesota Department of Veterans Affairs
Image

NightWare receives grant of $100,000 to support a 50-person clinical trial at the Minneapolis VA Health Care System

Read More
(opens in a new tab)